What is the FDA approved long acting injectable for schizophrenia?
•
5 min read
According to research, a significant portion of patients with schizophrenia struggle with adherence to daily oral medication regimens, making long-acting injectables (LAIs) an important treatment option. Several LAIs have received FDA approval to help manage schizophrenia symptoms and reduce the risk of relapse.
